Related Experiment Video
Updated: Jul 9, 2026

Quantification of Hypopigmentation Activity In Vitro
Published on: March 6, 2019
Serum levels of pigmentation markers are elevated in patients undergoing hemodialysis
Kazutaka Murakami1, Kazumasa Wakamatsu, Yukiko Nakanishi
1Department of Nephrology, School of Medicine, Fujita Health University, Toyoake, Aichi, Japan.
Background:
Diffuse hyperpigmentation is common among patients with chronic renal failure undergoing hemodialysis (HD). We have examined serum levels of 5-S-cysteinyldopa (5SCD, a pheomelanin precursor), pheomelanin, eumelanin, and protein-bound (PB-) 3,4-dihydroxyphenylalanine (DOPA) and PB-5SCD in HD patients.
Methods:
Pheomelanin and eumelanin were assayed by chemical degradation methods.
Results:
Serum levels of free 5SCD in HD patients (n = 16) were 9-fold higher than in healthy controls (n = 16). Levels of pheomelanin in HD patients were 2.6-fold higher than in controls, while levels of eumelanin did not differ between HD patients and controls. Levels of PB-DOPA and PB-5SCD in HD patients were approximately 1.5-fold higher than in controls. Serum levels of free 5SCD were positively correlated to the duration of HD therapy.
Conclusions:
The high constitutive levels of free 5SCD, pheomelanin, and PB-DOPA in the blood may be deteriorating in HD patients through the production of reactive oxygen species.
Related Concept Videos
Pigmentation
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
Hemodialysis III: Nursing Management
Serum Studies: Renal Function Tests
Hemodialysis II: Procedure and Complications
Chronic Kidney Disease II: Clinical Manifestations
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
